{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:01:49Z","timestamp":1770555709881,"version":"3.49.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Glioblastomas (GBM) are the most common and aggressive form of primary malignant brain tumor in the adult population, and, despite modern therapies, patients often develop recurrent disease, and the disease remains incurable with median survival below 2 years. Resistance to bevacizumab is driven by hypoxia in the tumor and evofosfamide is a hypoxia-activated prodrug, which we tested in a phase 2, dual center (University of Texas Health Science Center in San Antonio and Dana Farber Cancer Institute) clinical trial after bevacizumab failure. Tumor hypoxic volume was quantified by 18F-misonidazole PET. To identify circulating metabolic biomarkers of tumor hypoxia in patients, we used a high-resolution liquid chromatography-mass spectrometry-based approach to profile blood metabolites and their specific enantiomeric forms using untargeted approaches. Moreover, to evaluate early response to treatment, we characterized changes in circulating metabolite levels during treatment with combined bevacizumab and evofosfamide in recurrent GBM after bevacizumab failure. Gamma aminobutyric acid, and glutamic acid as well as its enantiomeric form D-glutamic acid all inversely correlated with tumor hypoxia. Intermediates of the serine synthesis pathway, which is known to be modulated by hypoxia, also correlated with tumor hypoxia (phosphoserine and serine). Moreover, following treatment, lactic acid was modulated by treatment, likely in response to a hypoxia mediated modulation of oxidative vs glycolytic metabolism. In summary, although our results require further validation in larger patients\u2019 cohorts, we have identified candidate metabolic biomarkers that could evaluate the extent of tumor hypoxia and predict the benefit of combined bevacizumab and evofosfamide treatment in GBM following bevacizumab failure.<\/jats:p>","DOI":"10.3389\/fonc.2022.900082","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T08:56:01Z","timestamp":1664182561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide"],"prefix":"10.3389","volume":"12","author":[{"given":"Alessia","family":"Lodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayon","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Burgman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Stephen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tiziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: A randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.01.010","article-title":"Hypoxia-mediated mechanisms associated with antiangiogenic treatment resistance in glioblastomas","volume":"187","author":"Mahase","year":"2017","journal-title":"Am J pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy015","article-title":"Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study","volume":"20","author":"Brenner","year":"2018","journal-title":"Neuro Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1038\/s41598-021-81841-0","article-title":"Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma","volume":"11","author":"Brenner","year":"2021","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0895","article-title":"Molecular pathways: Hypoxia-activated prodrugs in cancer therapy","volume":"23","author":"Baran","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40170-014-0026-z","article-title":"Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302","volume":"3","author":"Wojtkowiak","year":"2015","journal-title":"Cancer Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0491","article-title":"Metabolic and physiologic imaging biomarkers of the tumor microenvironment predict treatment outcome with radiation or a hypoxia-activated prodrug in mice","volume":"78","author":"Matsumoto","year":"2018","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-84331-5","article-title":"Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18 f-FMISO PET","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22694","article-title":"Metabolomic signature of brain cancer","volume":"56","author":"Pandey","year":"2017","journal-title":"Mol Carcinog."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2567","article-title":"A prospective analysis of circulating plasma metabolites associated with ovarian cancer risk","volume":"80","author":"Zeleznik","year":"2020","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056422","article-title":"Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease","volume":"8","author":"Lodi","year":"2013","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3198","article-title":"HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer","volume":"27","author":"Wang","year":"2014","journal-title":"NMR Biomed"},{"key":"B14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41523-021-00262-4","article-title":"Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women","volume":"7","author":"Zeleznik","year":"2021","journal-title":"NPJ Breast Cancer."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1593\/neo.81396","article-title":"Early stage diagnosis of oral cancer using 1H NMR-based metabolomics","volume":"11","author":"Tiziani","year":"2009","journal-title":"Neoplasia."},{"key":"B16","doi-asserted-by":"publisher","first-page":":1\u201318","DOI":"10.1038\/s41698-017-0024-z","article-title":"Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism","volume":"1","author":"Lodi","year":"2017","journal-title":"NPJ Precis Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1917362117","article-title":"Enzyme-mediated depletion of serum l-met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity","volume":"117","author":"Lu","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mc.23163","article-title":"Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-b cell acute lymphoblastic leukemia","volume":"59","author":"Sweeney","year":"2020","journal-title":"Mol Carcinog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchromb.2014.02.042","article-title":"Metabolome analysis for discovering biomarkers of gastroenterological cancer","volume":"966","author":"Suzuki","year":"2014","journal-title":"J Chromatogr B Analyt Technol BioMed Life Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1039\/C4MB00407H","article-title":"Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Biosyst"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16739","article-title":"Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget."},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2334-14-53","article-title":"A metabolic biosignature of early response to anti-tuberculosis treatment","volume":"14","author":"Mahapatra","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43911","DOI":"10.1038\/srep43911","article-title":"D-glutamate is metabolized in the heart mitochondria","volume":"7","author":"Ariyoshi","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-012-1346-3","article-title":"D-amino acids in brain neurotransmission and synaptic plasticity","volume":"43","author":"Billard","year":"2012","journal-title":"Amino Acids"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.10.047","article-title":"Altered profiles and metabolism of l- and d-amino acids in cultured human breast cancer cells vs. non-tumorigenic human breast epithelial cells","volume":"164","author":"Du","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/chir.23155","article-title":"Enantioanalysis of tryptophan in whole blood samples using stochastic sensors-a screening test for gastric cancer","volume":"32","author":"Ilie-Mihai","year":"2020","journal-title":"Chirality."},{"key":"B27","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41598-020-57878-y","article-title":"Development of a cognitive function marker based on d-amino acid proportions using new chiral tandem LC-MS\/MS systems","volume":"10","author":"Kimura","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26137","DOI":"10.1038\/srep26137","article-title":"Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease","volume":"6","author":"Kimura","year":"2016","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2015.01.015","article-title":"Optimization and validation of a chiral GC-MS method for the determination of free d-amino acids ratio in human urine: application to a gestational diabetes mellitus study","volume":"107","author":"Lorenzo","year":"2015","journal-title":"J Pharm BioMed Anal"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-006-0262-9","article-title":"High concentrations of d-amino acids in human gastric juice","volume":"32","author":"Nagata","year":"2007","journal-title":"Amino Acids"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-020-02575-y","article-title":"Enantioanalysis of glutamine-a key factor in establishing the metabolomics process in gastric cancer","volume":"412","author":"Stefan-van Staden","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1759091417713905","DOI":"10.1177\/1759091417713905","article-title":"Heterogeneity of d-serine distribution in the human central nervous system","volume":"9","author":"Suzuki","year":"2017","journal-title":"ASN Neuro."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1039\/C7NR07337B","article-title":"Non-invasive detection of gastric cancer relevant d-amino acids with luminescent DNA\/silver nanoclusters","volume":"9","author":"Zhang","year":"2017","journal-title":"Nanoscale."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.05.003","article-title":"IDH mutations in acute myeloid leukemia","volume":"43","author":"Rakheja","year":"2012","journal-title":"Hum Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2010.07.002","article-title":"IDH mutations in glioma and acute myeloid leukemia","volume":"16","author":"Dang","year":"2010","journal-title":"Trends Mol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.06.023","article-title":"Hypoxia induces production of l-2-Hydroxyglutarate","volume":"22","author":"Intlekofer","year":"2015","journal-title":"Cell Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cmet.2015.06.021","article-title":"Hypoxia-mediated increases in l-2-hydroxyglutarate coordinate the metabolic response to reductive stress","volume":"22","author":"Oldham","year":"2015","journal-title":"Cell Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.0c05325","article-title":"Novel strategy for untargeted chiral metabolomics using liquid chromatography-high resolution tandem mass spectrometry","volume":"93","author":"Pandey","year":"2021","journal-title":"Anal Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ab.2008.01.037","article-title":"Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy","volume":"377","author":"Tiziani","year":"2008","journal-title":"Anal Biochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0530","article-title":"PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis","volume":"76","author":"Samanta","year":"2016","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non\u2013small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nat Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2016.03.006","article-title":"Increased expression of PHGDH and prognostic significance in colorectal cancer","volume":"9","author":"Jia","year":"2016","journal-title":"Trans Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":":1465\u20139","DOI":"10.1097\/IGC.0b013e3182a0c068","article-title":"Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer","volume":"23","author":"Jing","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J neurochem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy083","article-title":"An active role for neurons in glioma progression: making sense of scherer\u2019s structures","volume":"20","author":"Gillespie","year":"2018","journal-title":"Neuro-oncology."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.012","article-title":"Integrin \u03b1v\u03b28-mediated TGF-\u03b2 activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation","volume":"42","author":"Worthington","year":"2015","journal-title":"Immunity."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-017-2212-1","article-title":"Glutamine addiction in gliomas","volume":"42","author":"M\u00e1rquez","year":"2017","journal-title":"Neurochem Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/cancers12020310","article-title":"Targeting glutamine addiction in gliomas","volume":"12","author":"Obara-Michlewska","year":"2020","journal-title":"Cancers."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201695204","article-title":"Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype","volume":"36","author":"Semenza","year":"2017","journal-title":"EMBO J"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.900082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T08:56:04Z","timestamp":1664182564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.900082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":50,"alternative-id":["10.3389\/fonc.2022.900082"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.900082","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"article-number":"900082"}}